secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0001104659-23-101208
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros shareholders approved authorized share increase to 250M and incentive plan share increase
--------------------------------------------------------------------------------

- Authorized common shares increased from 150M to 250M via charter amendment filed Sept 14, 2023.
- Incentive plan share pool increased by 2.5M shares to 2.76M total, approved by stockholders.
- Issuance of shares underlying convertible preferred stock and warrants (over 20% of outstanding) also approved.
- Vote results: Share increase 728,964 for, 20,658 against; incentive plan 685,428 for, 64,669 against.
- Special meeting held Sept 14, 2023; all four proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465923101208/0001104659-23-101208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465923101208/tm2326218d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-101208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer